Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.6240
-0.0379 (-5.73%)
At close: Nov 5, 2026, 4:00 PM EST
0.6315
+0.0075 (1.20%)
After-hours: Nov 5, 2026, 7:54 PM EST
Daré Bioscience Employees
As of December 31, 2025, Daré Bioscience had 24 total employees, including 21 full-time and 3 part-time employees. The number of employees increased by 1 or 4.35% compared to the previous year. That makes Daré Bioscience the 37,808th largest employer in the world and 5,387th in the United States.
Employees
24
Change (1Y)
1
Growth (1Y)
4.35%
Revenue / Employee
$56,914
Profits / Employee
-$457,798
Market Cap
12.27M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | 1 | 4.35% | 21 | 3 |
| Dec 31, 2024 | 23 | -3 | -11.54% | 21 | 2 |
| Dec 31, 2023 | 26 | -4 | -13.33% | 23 | 3 |
| Dec 31, 2022 | 30 | 2 | 7.14% | 25 | 5 |
| Dec 31, 2021 | 28 | 5 | 21.74% | 20 | 8 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 138 |
| Fractyl Health | 100 |
| Passage Bio | 24 |
| BioCardia | 21 |
| Lipocine | 14 |
| Psyence Biomedical | 12 |
| NewcelX | 12 |
| Tvardi Therapeutics | 12 |
DARE News
- 1 day ago - Daré Bioscience to Present at Stifel's 2026 Healthcare Conference - GlobeNewsWire
- 6 days ago - Dare Bioscience receives additional $1.5M funding installment for DARE-LARC1 - TheFly
- 6 days ago - Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum - GlobeNewsWire
- 8 days ago - Daré Bioscience Addresses New National Focus on Women's Health in Virtual Investor “What This Means” Discussion - GlobeNewsWire
- 9 days ago - Daré Bioscience Proxy statement: Proxy filing - Filings
- 10 days ago - Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly - GlobeNewsWire
- 10 days ago - Dare Bioscience initiated with a Buy at Ladenburg - TheFly
- 17 days ago - Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer - GlobeNewsWire